Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 9
1993 2
1994 4
1995 3
1996 2
1997 7
1998 11
1999 4
2000 8
2001 8
2002 9
2003 6
2004 1
2005 2
2007 6
2008 6
2009 9
2010 5
2011 6
2012 4
2013 4
2014 4
2015 6
2016 8
2017 6
2018 7
2019 3
2020 4
2021 4
2022 7
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Results by year

Filters applied: . Clear all
Page 1
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia.
Kesic V, Carcopino X, Preti M, Vieira-Baptista P, Bevilacqua F, Bornstein J, Chargari C, Cruickshank M, Erzeneoglu E, Gallio N, Gultekin M, Heller D, Joura E, Kyrgiou M, Madić T, Planchamp F, Regauer S, Reich O, Esat Temiz B, Woelber L, Zodzika J, Stockdale C. Kesic V, et al. Among authors: joura e. Int J Gynecol Cancer. 2023 Apr 3;33(4):446-461. doi: 10.1136/ijgc-2022-004213. Int J Gynecol Cancer. 2023. PMID: 36958755 Free PMC article. Review.
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.
Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, Pitisuttithum P, Restrepo JA, Stuart G, Woelber L, Yang YC, Cuzick J, Garland SM, Huh W, Kjaer SK, Bautista OM, Chan IS, Chen J, Gesser R, Moeller E, Ritter M, Vuocolo S, Luxembourg A; Broad Spectrum HPV Vaccine Study. Joura EA, et al. N Engl J Med. 2015 Feb 19;372(8):711-23. doi: 10.1056/NEJMoa1405044. N Engl J Med. 2015. PMID: 25693011 Free article. Clinical Trial.
Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27-45 years.
Maldonado I, Plata M, Gonzalez M, Correa A, Nossa C, Giuliano AR, Joura EA, Ferenczy A, Ronnett BM, Stoler MH, Jin Zhou H, Joshi A, Das R, Bautista O, Group T, Luxembourg A, Saah A, Buchwald UK. Maldonado I, et al. Among authors: joura ea. Hum Vaccin Immunother. 2022 Nov 30;18(5):2078626. doi: 10.1080/21645515.2022.2078626. Epub 2022 Jul 19. Hum Vaccin Immunother. 2022. PMID: 35853188 Free PMC article.
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.
Preti M, Joura E, Vieira-Baptista P, Van Beurden M, Bevilacqua F, Bleeker MCG, Bornstein J, Carcopino X, Chargari C, Cruickshank ME, Erzeneoglu BE, Gallio N, Heller D, Kesic V, Reich O, Stockdale CK, Temiz BE, Woelber L, Planchamp F, Zodzika J, Querleu D, Gultekin M. Preti M, et al. Among authors: joura e. J Low Genit Tract Dis. 2022 Jul 1;26(3):229-244. doi: 10.1097/LGT.0000000000000683. Epub 2022 Jun 21. J Low Genit Tract Dis. 2022. PMID: 35763611 Free PMC article.
Prophylactic HPV vaccines in patients with HPV-associated diseases and cancer.
Reuschenbach M, Doorbar J, Del Pino M, Joura EA, Walker C, Drury R, Rauscher A, Saah AJ. Reuschenbach M, et al. Among authors: joura ea. Vaccine. 2023 Oct 6;41(42):6194-6205. doi: 10.1016/j.vaccine.2023.08.047. Epub 2023 Sep 12. Vaccine. 2023. PMID: 37704498 Free article. Review.
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
Huh WK, Joura EA, Giuliano AR, Iversen OE, de Andrade RP, Ault KA, Bartholomew D, Cestero RM, Fedrizzi EN, Hirschberg AL, Mayrand MH, Ruiz-Sternberg AM, Stapleton JT, Wiley DJ, Ferenczy A, Kurman R, Ronnett BM, Stoler MH, Cuzick J, Garland SM, Kjaer SK, Bautista OM, Haupt R, Moeller E, Ritter M, Roberts CC, Shields C, Luxembourg A. Huh WK, et al. Among authors: joura ea. Lancet. 2017 Nov 11;390(10108):2143-2159. doi: 10.1016/S0140-6736(17)31821-4. Epub 2017 Sep 5. Lancet. 2017. PMID: 28886907 Clinical Trial.
ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?
Kamani MO, Kyrgiou M, Joura E, Zapardiel I, Grigore M, Arbyn M, Preti M, Planchamp F, Gultekin M. Kamani MO, et al. Among authors: joura e. Int J Gynecol Cancer. 2023 Apr 3;33(4):462-464. doi: 10.1136/ijgc-2023-004295. Int J Gynecol Cancer. 2023. PMID: 36889817 No abstract available.
From the monovalent to the nine-valent HPV vaccine.
Pils S, Joura EA. Pils S, et al. Among authors: joura ea. Clin Microbiol Infect. 2015 Sep;21(9):827-33. doi: 10.1016/j.cmi.2015.05.001. Epub 2015 May 14. Clin Microbiol Infect. 2015. PMID: 25980355 Free article. Review.
166 results